Chimerism Multiplex II Kit: Pioneering Advanced Chimerism Analysis

In the intricate landscape of molecular biology, one area that holds significant clinical promise is the analysis of molecular chimerism. The Chimerism Multiplex II Kit provides a robust toolset for researchers and clinicians aiming to shed light on the intricacies of allogenic transplantation and its long-term implications, such as graft-versus-host disease, rejection, or relapse.

Central to the Chimerism Multiplex II Kit is its multiplexed real-time PCR diagnostic assay. Designed with a precise blend of oligonucleotides and fluorescent hydrolysis probes, this kit provides simultaneous analysis of 16 insertion/deletion polymorphisms (INDELs) in 8 independent PCR reactions. What sets it apart is its ability to isolate informative markers found in the transplant recipient but absent in the donor, delivering unparalleled accuracy and insight.

The art of this kit lies in its multiplexing capabilities. In a single procedural step, it identifies the presence or absence of 16 polymorphic markers. Each marker is uniquely tagged with a specific fluorophore, rendering results that are not just accurate but also unambiguous. Notably, the kit includes gender-specific SRY markers and RhD blood type markers as built-in elements, obviating the need for additional tests to establish informativity.

Features Crafted for Research Excellence

• Multiple Biomarkers: The kit analyzes a comprehensive set of 34 markers across 18 chromosomes, offering a broad spectrum of data points.
• Flexible Sample Types: While optimal for peripheral blood, the kit can also work with bone marrow samples, providing versatility in the lab.
• ISO Compliance: Meeting the stringent ISO 9001 quality standards, the kit provides assured reliability in its performance.

Embracing the Future of Chimerism Analysis

The Chimerism Multiplex II Kit represents a paradigm shift in the domain of molecular chimerism analysis. It invites professionals to explore a new era of targeted, personalized treatment modalities post-allogenic transplantation. For those who are at the frontier of molecular biology and patient care, this is your toolkit for innovation. The future of chimerism analysis is not just approaching; it’s already here.